USPTO serial 99714780
Serial No. 99714780
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROTH, BENJAMIN H.
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 99714780?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Personal electronic devices used to track reproductive hormones and metabolic state for scientific purposes; wearable hormone and metabolic state trackers for scientific purposes; wearable electronic devices, namely, smartwatches, smart bracelets, and wristbands in the nature of smart bracelets, all that are comprised of computer hardware and recorded software that communicates data to personal digital assistants, smart phones, and personal computers through internet websites and other computer and electronic communication networks; sensors for scientific use to be worn by a human to gather human biometric data; downloadable mobile application and computer software using artificial intelligence and machine learning for the collection, organization, storage and transmission of data and information from the wearable medical device and for analyzing women's health data from implantable and wearable medical devices; downloadable mobile application and computer software using artificial intelligence and machine learning for use in monitoring and tracking hormone health, period cycles, and fertility; downloadable mobile application and computer software using artificial intelligence and machine learning for alerts, messages, emails, and reminders, and for recording, organizing, transmitting, manipulating, reviewing, and receiving text, data, audio, image and digital files, all relating to women's health; downloadable mobile application and computer software using artificial intelligence and machine learning for recording medical data in the field of women's health; downloadable mobile application and computer software using artificial intelligence and machine learning for providing medical information in the field of women's health; downloadable mobile application and computer software using artificial intelligence and machine learning for retrieving, analyzing, and generating reports on women's health from data generated by wearable digital electronic devices; downloadable mobile application and computer software using artificial intelligence and machine learning for enabling users to receive personalized recommendations in the field of women's health; downloadable mobile application and computer software using artificial intelligence and machine learning for tracking, collecting and analyzing health data for use in conducting health risk assessments, recommending preventative health measures, and condition management, all in the field of women's health; downloadable mobile application and computer software using artificial intelligence and machine learning for analyzing voice data to provide personalized hormone health insights; downloadable computer software using artificial intelligence and machine learning for natural language processing, generation, understanding and analysis; downloadable computer software using artificial intelligence and machine learning for creating and generating text; downloadable computer software using artificial intelligence and machine learning for voice recognition; wearable monitors used to store, relay, track, measure and display biometric data for scientific purposes | ACTIVE | — |
| 010 | Wearable monitors used to store, relay, track, measure and display biometric data for medical purposes; wearable medical device in the nature of monitors for measuring and analyzing the body's autonomic nervous system, physical parameters and other physiological data, bio-signals and bodily behavior, and for displaying, storing, sending, transmitting and receiving instructions and data relating to any of the above; medical health monitors with built-in biometric sensor hardware and incorporating recorded software for monitoring temperature, heart rate, blood oxygen saturation, blood glucose levels, respiratory conditions, respiratory events, blood pressure, and vital signs; personal electronic devices used to track reproductive hormones and metabolic state for medical purposes; wearable hormone and metabolic state trackers for medical purposes | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable software using artificial intelligence and machine learning for the collection, organization, storage and transmission of data and information from the wearable medical device and for analyzing women’s health data from implantable and wearable medical devices; providing temporary use of non-downloadable software using artificial intelligence and machine learning for use in monitoring and tracking hormone health, period cycles, and fertility; providing temporary use of non-downloadable software using artificial intelligence and machine learning for alerts, messages, emails, and reminders, and for recording, organizing, transmitting, manipulating, reviewing, and receiving text, data, audio, image and digital files, all relating to women’s health; providing temporary use of non-downloadable software using artificial intelligence and machine learning for recording medical data in the field of women’s health; providing temporary use of non-downloadable software using artificial intelligence and machine learning for providing medical information in the field of women’s health; providing temporary use of non-downloadable software using artificial intelligence and machine learning for retrieving, analyzing, and generating reports on women’s health from data generated by wearable digital electronic devices; providing temporary use of non-downloadable software using artificial intelligence and machine learning for enabling users to receive personalized recommendations in the field of women’s health; providing temporary use of non-downloadable software using artificial intelligence and machine learning for tracking, collecting and analyzing health data for use in conducting health risk assessments, recommending preventative health measures, and condition management, all in the field of women’s health; providing temporary use of non-downloadable software using artificial intelligence and machine learning for analyzing voice data to provide personalized hormone health insights; providing temporary use of non-downloadable software using artificial intelligence and machine learning for natural language processing, generation, understanding and analysis; providing temporary use of non-downloadable software using artificial intelligence and machine learning for creating and generating text; providing temporary use of non-downloadable software using artificial intelligence and machine learning for voice recognition | ACTIVE | — |
| 044 | Healthcare services, namely, services to provide personalized health insights in the field of women’s health; healthcare services, namely, analyzing voice data to provide personalized hormone health insights; providing information and advice in the fields of women’s health; individual health assessment services; health counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 13, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 13, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 13, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 6, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 31, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2026 | NWAP | NEW APPLICATION ENTERED | — |